Knowthestock.com
CYAN - Cyanotech Corp.

Hold

Moderate Growth and Improving

42%

based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 1.4%
Operating Income Growth is -92.02%
Net Income Growth is 137.73%
Earnings Per Share (EPS) Growth is 150.0%
Net Margin is 2.84%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 2.6
Debt Ratio is 0.45
Current Debt to Net Income Ratio is 2.4
Total Debt to Total Assets Ratio is 0.27
Cash Flow is MODERATE
Cash from Operations Growth is 93.08%
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Cyanotech Corp. (CYAN) - www.cyanotech.com
Cyanotech Corporation, a world leader in microalgae technology for more than 30 years, produces BioAstin® Hawaiian Astaxanthin® and Hawaiian Spirulina Pacifica®. These all-natural, dietary ingredients and supplements leverage our experience and reputation for quality, building nutritional brands which promote health and well-being. The Company's mission is to fulfill the promise of whole health through Hawaiian microalgae. Cyanotech's BioAstin® offers superior antioxidant activity which supports skin, eye and joint health, as well as recovery from exercise*. Cyanotech's Spirulina products offer nutrition that supports cardiovascular health and immunity*. All Cyanotech products are produced from microalgae grown at our 96-acre facility in Kona, Hawaii using patented and proprietary technology and are Generally Recognized as Safe (GRAS) for use in food products. Cyanotech sells its products direct to consumers at retail locations in the United States and online at www.nutrex-hawaii.com and also distributes to dietary supplement, nutraceutical and cosmeceutical manufacturers and marketers. The Company is regulated by the Food and Drug Administration ('FDA').
Exchange - NASDAQ CAPITAL MARKET
Industry - Medicinal and Botanical Manufacturing
Sector - Manufacturing
CEO -
    Close


Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.